← Back to Search

Present Centered Psychotherapy for PTSD (MERA Trial)

N/A

Recruiting

Led By Shannon R. Miles, PhD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Agreement not to change psychotropic medications through the duration of the study.

Agreement not to change psychotropic medications through the duration of the study

Must not have

Meets diagnostic criteria for bipolar disorder or psychotic disorder

Timeline

Screening 3 weeks

Treatment Varies

Follow Up treatment group differences in ebp initiation at 6 months posttreatment.

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if a 3-session emotion regulation treatment can help veterans with PTSD reduce impulsive aggression and better prepare for PTSD treatment.

Who is the study for?

This trial is for Veterans who served since 9/11, have PTSD or subthreshold PTSD, and show impulsive aggression. They must not change their psychotropic medications during the study and need an independent observer to verify aggressive acts.

What is being tested?

The MERA trial compares a new 3-session emotion regulation treatment with a control group to see if it can reduce impulsive aggression in Veterans and prepare them for PTSD treatment.

What are the potential side effects?

Since this is a psychotherapy intervention, typical side effects associated with medications are not expected. However, participants may experience emotional discomfort when discussing traumatic experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I agree not to change my mental health medications during the study.

Select...

I agree not to change my mental health medications during the study.

Select...

I have been diagnosed with PTSD or show symptoms of it.

Select...

I am a veteran who served in a combat zone after 9/11.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been diagnosed with bipolar disorder or a psychotic disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ treatment group differences in ebp initiation at 6 months posttreatment.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~treatment group differences in ebp initiation at 6 months posttreatment.

This trial's timeline: 3 weeks for screening, Varies for treatment, and treatment group differences in ebp initiation at 6 months posttreatment. for reporting.